
You can purchase shares of abrdn Life Sciences (NYSE:HQL) through any online brokerage.
There are no as such competitors for abrdn Life Sciences.
There is no analysis for abrdn Life Sciences to provide a consensus price target.
The stock price for abrdn Life Sciences (NYSE: HQL) is $17.85 last updated October 26, 2026 at 10:03 AM EDT.
There are no upcoming dividends for abrdn Life Sciences.
abrdn Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for abrdn Life Sciences.
abrdn Life Sciences is in the Financial Services sector and Asset Management industry. They are listed on the NYSE.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in...